Journal of Nuclear Medicine | |
Imaging Atherosclerosis and Vulnerable Plaque | |
Zahi A. Fayad1  David K. Glover1  Mehran M. Sadeghi1  Gregory M. Lanza1  Lynne L. Johnson1  | |
关键词: clinical cardiology; molecular imaging; vascular; atherosclerosis; plaque; vascular remodeling; | |
DOI : 10.2967/jnumed.109.068163 | |
学科分类:医学(综合) | |
来源: Society of Nuclear Medicine | |
【 摘 要 】
Identifying patients at high risk for an acute cardiovascular event such as myocardial infarction or stroke and assessing the total atherosclerotic burden are clinically important. Currently available imaging modalities can delineate vascular wall anatomy and, with novel probes, target biologic processes important in plaque evolution and plaque stability. Expansion of the vessel wall involving remodeling of the extracellular matrix can be imaged, as can angiogenesis of the vasa vasorum, plaque inflammation, and fibrin deposits on early nonocclusive vascular thrombosis. Several imaging platforms are available for targeted vascular imaging to acquire information on both anatomy and pathobiology in the same imaging session using either hybrid technology (nuclear combined with CT) or MRI combined with novel probes targeting processes identified by molecular biology to be of importance. This article will discuss the current state of the art of these modalities and challenges to clinical translation.
【 授权许可】
Unknown
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO201912010197884ZK.pdf | 2109KB | download |